Management Team


Christian Horn

Founder and executive director. Responsible for international business development for 20 years in CEO/board positions in cancer detection focused companies. Led IPO of cancer diagnostics company at Oslo Stock Exchange (main list). BBA from the College of William & Mary, USA and Advanced Management &. Leadership Program, Oxford University.
EXEC. Board Member, AI/ip development

Hans Gangeskar

Hans Gangeskar leads DeepX’s AI/IP development and U.S. market entry. Hans is co-founder and former CEO of Nurx, a US-based $100m+ revenue telemedicine company, now merged with Thirty Madison. Hans is a computer science/mathematics graduate from Cambridge University, UK and holds a J.D. from George Washington University Law School. 

Nadya Gordeeva

CFO with extensive business financial management, business leadership, and operating experience. Launched and led financial management for a fintech startup (United Income). Previously, background in financial services (Capital One), and more than 10 years of audit advisory experience from PwC, USA. MBA in finance from Government Academy of Economy, Moscow, Russia.
Head of Product

Laurens Kraal

Former Head of Product at uBiome Inc., a microbiome diagnostics company, and research fellow at the Berkeley Institute for Data Science. Dr. Kraal received his PhD from UCSF, during which he was also involved with multiple life-sciences start-ups. He also holds degrees from University of Groningen and Utrecht University. 
Chief Medical Officer

Dr. David Swanson

Dermatologist and vice chairman for medical dermatology at at the department of dermatology at the Mayo Clinic, US. Dr. Swanson’s primary research area is on non-invasive imaging technologies to diagnose skin cancer. Board advisor and lead author on several DeepX publications. MD University of Minnesota medical school. BA Saint Johns University, USA.

Mette Valeur

General Manager at ScreenCancer and global operational and systems responsibility for the group. 20 years in leadership positions in insurance and customer centric organizations, incl. Dixons UK, Vesta and Skandia. MBA from Oslo Business School, and attended Harvard Business School, USA for Building & Leading Customer-Centric Organizations.

Medical / Scientific / Commercial Advisory Board

Dr. Paola Pasquali

Dermatologist and specialist in skin cancer and noninvasive diagnosis techniques. Dr. Pasquali is a former President of the International Society of Teledermatology and Chairman of the International Affairs Committee of the American Academy of Dermatology and EADV School. In addition to being an internationally renowned speaker, Dr. Pasquali coordinates the Dermatology Service at Pius Hospital de Valls in the public sector. Dr. Pasquali is also the editor of four books, including Skin Cancer: A Practical Approach, Cryosurgery, A Practical Manual, Photography in Clinical Medicine and Textbook of Primary Care Dermatology.

Dr. Rhonda Low

Dr. Low is Clinical Associate Professor in the Department of Family & Community Medicine at the University of British Columbia. She is also a fulltime practicing family physician in Vancouver and an executive health physician at Mayo Clinic in Arizona. She has a special interest in Continuing Medical Education for primary care practitioners, co-chairing one of the largest annual conferences in Canada. Dr Low is also a journalist. She was the health anchor for an evening newscast on a Canadian national affiliate television station for 15 years, has written regular health columns for local magazines, moderates community health events and is currently a regular medical commentator on television and radio

Prof. Knut Stamnes

Professor at the Department of Physics and Engineering Physics at Stevens Institute of Technology. Co-founder of Balter Medical and developed Balter Medical based on work done for NASA space agency. Specialist in Optical Transfer Diagnosis technology.

Prof. Jakob Stamnes

Co-founder of Balter Medical, and specialist in Optical Transfer Diagnosis technology. Professor Emeritus of Physics at the University of Bergen, with more than 200 publications.

Xavier Yon

Xavier Yon is an experienced healthcare executive with an extensive background in dermatology. Previous roles include executive positions with Pfizer, Solvay, Alcon and most notably as Chief Executive Officer of Galderma for 17 years.

Andre Esteva

Andre Esteva is a leading researcher and entrepreneur in medical artificial intelligence, currently serving as CEO of ArteraAI, with a background that includes roles at Salesforce Research, Google, and founding four companies. His acclaimed research, focused on AI diagnostics and precision medicine, has been featured in top scientific journals and media outlets worldwide, underpinned by a PhD in AI from Stanford and degrees in Electrical Engineering and Pure Math from UT-Austin.

Mariano de Socarraz

Chief Executive Office of CorePlus Servicos Clinicos y Patologicos, LLC an anatomic clinical laboratory. Head of Syndeo, LLC a healthcare IT software development enterprise. Both focus on development and implementation of digital pathology and AI solutions.

Giovanni Monti

Founder of Option 5 Health. Member of the Board of Advisors of Photon. External Advisor at Bain & Company. Visiting Senior Fellow at LSE Health. Former SVP Healthcare Services at Walgreens Boots Alliance.​

David Nikka

Former COO of Exact Sciences. Broadly experienced senior executive in diagnostics, medical devices and pharmaceuticals at companies including Dermira, Abiomed and Genzyme with responsibilities for corporate and product development, regulatory, clinical affairs, human resources and division general management. Co-founder of ScreenCancer, Inc.

Ben Kent

Ben has held a range of executive positions in the healthcare sector, including CFO and COO of Doctor Care Anywhere, CFO of Simplyhealth, Group Director of Finance at Bupa, and interim CFO of DeepX Health. Ben is a graduate of the University of Oxford and Chartered Accountant.